Expert Sell-Side M&A Services for Biotech Companies

Our specialist M&A team are here to guide you through selling your biotech company

Sell-Side M&A Services for Biotech Companies

Many of the clients represented by Pivotal Scientific on the sell-side of a transaction, choose to use us to support their internal teams, or because they have little experience of selling their own business and desire an experienced guide. When you’re selling a biotech  business, you have taken time to set up and grow, and it can be challenging to watch the acquiring company probe your processes, strategies, and records. Pivotal Scientific acts as a bridge between owner operator and buyer, easing that journey, and allowing sellers to focus on continuing to run their business on a day-to-day basis, maintaining sales momentum.

The diverse requirements of our client base prompted us to offer a truly modular sell-side service, where you can select the areas of the process in which you need the most support. Alternatively, we are happy to manage the entire process from end-to-end, supporting you from valuation via business ready assessment (feasibility), through to post sale support. As this process is bespoke to each client, we recommend you book at call with one of our senior M&A practitioners to discuss your project, and how we can support you.
I would like to sell my companyView our M&A articles

Our Proven Sell-Side Process

Selling your business requires a structured approach. Our M&A experts ensure a seamless transition by guiding you through the following key stages:

 

I wish to dicuss a transaction

  1. Valuation

    • Our sector-specific expertise to provide a realistic valuation range for your company.
    • Strategic insight into how to achieve the highest value upon exit, and what you may need to work on prior to taking your company to market.

  2. Feasibility

    • Conducted with the aim of maximising the value of your company and ensuring it is ‘fit for sale’ in terms of margin, revenues, marketing, commercial go to market strategies etc.
    • Provides actions, plans and steps to achieve desired valuation via an in-depth review of your business, financials, documentation & process
    • We offer a roadmap to help you go to market for exit, showing strong growth and revenue streams from a well-structured organisation.

  3. Business Health checks

    • Post-feasibility, our health checks ensure your company is on the right trajectory
    • Critique in-line with established strategies and goals
    • Health checks are generally carried out 12 – 18 months post feasibility study, with a view to setting a timeline for exit that works for you and your company.

  4. Engagement

    • Preparation of sales brief and confidential information memorandum (CIM)
    • Identification, screening and selection of potential buyers
    • Support with NBOs (non-binding offers), or LOIs (letter of intent).
    • Corporate advisory throughout the due diligence process (including liaising with financial & legal professionals if required). We act as your sounding board and guide throughout the process.

  5. Additional support

    • Preparation of financial data
    • Inventory analysis and structure
    • Report writing
    • Product/portfolio gap analysis
    • Virtual data room (VDR) set-up and management

  6. Completion

    • Negotiation support on the final contracts and agreements
    • Deal structure – price and payment terms
    • In-field support for deal closure
    • Potential for post-transaction support with:
      • Working capital and completion accounts
      • Transition activities
      • Integration and communication

Client Success Stories: Ensuring Maximum Value for Sellers

Pivotal Scientific has successfully guided numerous biotech businesses through the sell-side process. One client, East Coast Bio, shares their experience of selling to Medix Biochemica:

  • I cannot speak highly enough of the service provided by Pivotal Scientific

    I am delighted to provide a testimonial for the services provided by Pivotal Scientific during the sale of my business, East Coast Bio, to Medix Biochemica.

    Stevan Hoyle, the project lead, demonstrated expertise and dedication instrumental to the entire transaction, resulting in a seamless and successful sale. One of the standout qualities of PSL was their commitment to understanding the intricacies of our business. They took the time to visit our site and thoroughly assess our operations, offering insights into inventory management that ultimately maximized the value of our assets. Furthermore, PSL played a pivotal role in negotiating the sale price and served as a trusted intermediary between both parties involved in the sale.

    In conclusion, I cannot speak highly enough of the service provided by Pivotal, their professionalism, expertise, and commitment to client satisfaction are commendable, and I would not hesitate to recommend their M&A advisory services to anyone seeking a seamless and successful transaction. Thank you once again to Stevan Hoyle and the entire team at PSL for their invaluable support and guidance.

    Sale of East Coast Bio, to Medix Biochemica, EastCoast Bio

  • Our Service includes:

    Our expert M&A team offers tailored support, including valuation, market positioning, and identification of potential buyers. We ensure that you receive the best possible outcome by leveraging our deep industry knowledge and extensive network. Ready to take the next step in selling your biotech business? Contact us to discuss how we can help you achieve a successful sale.

    1.  Valuation services (including value creation planning)
    2. Feasibility studies (how to get ‘fit for purpose’)
    3. Business planning – full strategic support for future corporate sale, including long-range planning
    4. Preparation of Confidential Information Memoranda (CIM) for presentation of your company to buyers
    5. Identification of potential buyers
    6. Introduction of your company to potential buyers
    7. Full end to end support